Concepedia

Xinli Li

XL

Statistics

Publications

38

Citations

1.9K

H-Index

23

Active since

2005

Affiliations

Nanjing Medical University(Current)

Jiangsu Province Hospital

Shanghai University

Harvard University

Tongji University

Xinli Li is an author at Nanjing Medical University specializing in cardiology, cardiovascular disease, and medicine.

ORCID

Publications per year

2005–2024

38

Publications

38

A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of the Effects of Qili Qiangxin Capsules in Patients With Chronic Heart Failure

Xinli Li, Jian Zhang, Jun Huang et al. · Journal of the American College of Cardiology · 2013 · 338 citations · Full text

, , +14

miR-17-3p Contributes to Exercise-Induced Cardiac Growth and Protects against Myocardial Ischemia-Reperfusion Injury

Jing Shi, Yihua Bei, Xiangqing Kong et al. · Theranostics · 2017 · 217 citations · Full text

, , +17

Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome

Gorav Batra, Tatevik Ghukasyan Lakic, Johan Lindbäck et al. · JAMA Cardiology · 2021 · 111 citations · Full text

, , +15

Inhibition of miR-155 Protects Against LPS-induced Cardiac Dysfunction and Apoptosis in Mice

Hui Wang, Yihua Bei, Peipei Huang et al. · Molecular Therapy — Nucleic Acids · 2016 · 101 citations · Full text

, , +16

ADAR2 increases in exercised heart and protects against myocardial infarction and doxorubicin-induced cardiotoxicity

Xiaoting Wu, Lijun Wang, Kai Wang et al. · Molecular Therapy · 2021 · 93 citations · Full text

, , +17

1–5 of 38